Autopsy report · NCT05379907

Observational Study of ctDNA in Resectable and Borderline Resectable Pancreatic Cancer

“Determined that the tumor analysis could not be performed in accordance with the protocol.”

The sponsor’s own words in the registry.

Life of this trial

• Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status

Withdrawn

Sponsor

Inova Health Care Services

Sponsor type

University, hospital or other

Conditions

Pancreatic Cancer

Interventions

SIGNATERA™ ctDNA testing

Participants

0

Sites

1

Countries

United States

Trials that died the same way

• Novel Triple-dose Tuberculosis Retreatment Regimens: How to Overcome Resistance Without Creating More
  “Feasibility of the clinical trial could not be confirmed at the different sites.” (63% match in meaning)
• The Effect of Cold Steam Application on Nausea and Vomiting
  “the researcher cannot collect data.” (59% match in meaning)
• Effects of Therapy With Sulfamylon® 5% Topical Solution Compared to a Historical Control Group
  “FDA request as study could not serve as the confirmatory trial.” (58% match in meaning)
• The Occurrence of Atrial Fibrillation After Totally Endoscopic Cardiac Surgery
  “After the passing of the principal investigator, the clinical trial could not be continued.” (58% match in meaning)
• DASH - Decision Making in Adolescent Sexual Health
  “This research was not conducted at UNM \& not Applicable Clinical Trial.” (57% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.